IMKELDI
Formula & Concentration
IMKELDI – imatinib 80 mg/mL oral solution
Manufacturer
Shorla Oncology Inc.
Indications
Chronic phase Philadelphia chromosome (+) CML; malignancy; accelerated phase Philadelphia chromosome (+) CML; lymphoid blast phase Philadelphia chromosome (+) CML; aggressive systemic mastocytosis; Philadelphia chromosome positive ALL; myeloid blast phase Philadelphia chromosome (+) CML; hypereosinophilic syndrome; dermatofibrosarcoma protuberans; chronic eosinophilic leukemia; unresect or metastatic CD117+ gastrointest stromal tumor; myelodysplastic, myeloproliferative diseases with PDGFR; adjuvant therapy of CD117+ gastrointest stromal tumor
Shelf Life and Storage
Controlled Room Temp (20-25°C)




